These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21241474)

  • 21. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early detection of iron overload in the heart: a key role for MRI!
    Baur LH
    Int J Cardiovasc Imaging; 2009 Dec; 25(8):789-90. PubMed ID: 19937124
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiac iron removal and functional cardiac improvement by different iron chelation regimens in thalassemia major patients.
    Cassinerio E; Roghi A; Pedrotti P; Brevi F; Zanaboni L; Graziadei G; Pattoneri P; Milazzo A; Cappellini MD
    Ann Hematol; 2012 Sep; 91(9):1443-9. PubMed ID: 22572843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular basal myocardial scarring detected by delayed enhancement magnetic resonance imaging predicts outcomes after surgical therapies for patients with ischemic mitral regurgitation and left ventricular dysfunction.
    Takeda K; Matsumiya G; Hamada S; Sakaguchi T; Miyagawa S; Yamauchi T; Sawa Y
    Circ J; 2011; 75(1):148-56. PubMed ID: 21099123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not associated with left ventricular function and myocardial fibrosis as assessed by cardiac magnetic resonance imaging.
    Emans ME; van der Putten K; Velthuis BK; de Vries JJ; Cramer MJ; America YG; Hillege HL; Meiss L; Doevendans PA; Braam B; Gaillard CA
    BMC Cardiovasc Disord; 2012 Sep; 12():76. PubMed ID: 22989293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation of myocardial T2* to right ventricular function in thalassaemia major.
    Alpendurada F; Carpenter JP; Deac M; Kirk P; Walker JM; Porter JB; Banya W; He T; Smith GC; Pennell DJ
    Eur Heart J; 2010 Jul; 31(13):1648-54. PubMed ID: 20413399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-mortem study of the association between cardiac iron and fibrosis in transfusion dependent anaemia.
    Kirk P; Sheppard M; Carpenter JP; Anderson L; He T; St Pierre T; Galanello R; Catani G; Wood J; Fucharoen S; Porter JB; Walker JM; Forni GL; Pennell DJ
    J Cardiovasc Magn Reson; 2017 Mar; 19(1):36. PubMed ID: 28343449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of CMR feature-tracking derived left ventricular strain in predicting myocardial iron overload and assessing myocardial contractile dysfunction in patients with thalassemia major.
    Ojha V; Ganga KP; Seth T; Roy A; Naik N; Jagia P; Gulati GS; Kumar S; Sharma S
    Eur Radiol; 2021 Aug; 31(8):6184-6192. PubMed ID: 33721061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial damage detected by late gadolinium enhancement cardiovascular magnetic resonance is associated with subsequent hospitalization for heart failure.
    Wong TC; Piehler KM; Zareba KM; Lin K; Phrampus A; Patel A; Moon JC; Ugander M; Valeti U; Holtz JE; Fu B; Chang CC; Mathier M; Kellman P; Butler J; Gheorghiade M; Schelbert EB
    J Am Heart Assoc; 2013 Nov; 2(6):e000416. PubMed ID: 24249712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure.
    Pennell DJ; Carpenter JP; Roughton M; Cabantchik Z
    J Cardiovasc Magn Reson; 2011 Sep; 13(1):45. PubMed ID: 21910880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients.
    Said Othman KM; Elshazly SA; Heiba NM
    Hematology; 2014 Oct; 19(7):380-7. PubMed ID: 24225039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic fatty replacement as risk marker for altered glucose metabolism and cardiac iron and complications in thalassemia major.
    Meloni A; Nobile M; Keilberg P; Positano V; Santarelli MF; Pistoia L; Spasiano A; Casini T; Putti MC; Cuccia L; Bitti PP; Messina G; Peritore G; Renne S; Grassedonio E; Quaia E; Cademartiri F; Pepe A
    Eur Radiol; 2023 Oct; 33(10):7215-7225. PubMed ID: 37115218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different patterns of myocardial iron distribution by whole-heart T2* magnetic resonance as risk markers for heart complications in thalassemia major.
    Meloni A; Restaino G; Borsellino Z; Caruso V; Spasiano A; Zuccarelli A; Valeri G; Toia P; Salvatori C; Positano V; Midiri M; Pepe A
    Int J Cardiol; 2014 Dec; 177(3):1012-9. PubMed ID: 25449516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial tissue characterization in Chagas' heart disease by cardiovascular magnetic resonance.
    Torreão JA; Ianni BM; Mady C; Naia E; Rassi CH; Nomura C; Parga JR; Avila LF; Ramires JA; Kalil-Filho R; Rochitte CE
    J Cardiovasc Magn Reson; 2015 Nov; 17():97. PubMed ID: 26581396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic dyssynchrony and impaired contractile reserve of the left ventricle in beta-thalassaemia major: an exercise echocardiographic study.
    Cheung YF; Yu W; Li SN; Lam WW; Ho YC; Wong SJ; Chan GC; Ha SY
    PLoS One; 2012; 7(9):e45265. PubMed ID: 23028894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation.
    Raphael CE; Mitchell F; Kanaganayagam GS; Liew AC; Di Pietro E; Vieira MS; Kanapeckaite L; Newsome S; Gregson J; Owen R; Hsu LY; Vassiliou V; Cooper R; Mrcp AA; Ismail TF; Wong B; Sun K; Gatehouse P; Firmin D; Cook S; Frenneaux M; Arai A; O'Hanlon R; Pennell DJ; Prasad SK
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):26. PubMed ID: 33685501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On myocardial siderosis and left ventricular dysfunction in hemochromatosis.
    Carpenter JP; Grasso AE; Porter JB; Shah F; Dooley J; Pennell DJ
    J Cardiovasc Magn Reson; 2013 Mar; 15(1):24. PubMed ID: 23509881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease.
    Ngu PJ; Butler M; Pham A; Roberts SK; Taylor AJ
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):629-36. PubMed ID: 26667447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
    Mordi I; Bezerra H; Carrick D; Tzemos N
    JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How early can myocardial iron overload occur in beta thalassemia major?
    Yang G; Liu R; Peng P; Long L; Zhang X; Yang W; Tan S; Pan H; Long X; He T; Anderson L; Lai Y
    PLoS One; 2014; 9(1):e85379. PubMed ID: 24465548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.